Berkshire’s Cash Bulk… And New Data In The Weight Loss Drug Race 11/4/24
CNBC's "Fast Money"
00:00
Market Dynamics and Drug Valuations
This chapter explores the stock fluctuations of Viking Therapeutics following new weight loss drug data, discussing competition and market expectations. A healthcare strategist joins to provide insights on trading strategies and the effects of potential acquisitions in the biotech landscape, while also examining the performance of precious metals amidst current economic trends.
Play episode from 36:58
Transcript
